Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (... COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt's Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.15 | -4.46428571429 | 3.36 | 4.6054 | 3.02 | 78834 | 3.89383286 | CS |
| 4 | 0.56 | 21.1320754717 | 2.65 | 4.6054 | 1.96 | 60775 | 3.3619918 | CS |
| 12 | 0.51 | 18.8888888889 | 2.7 | 4.6054 | 1.96 | 27883 | 3.28019448 | CS |
| 26 | -0.5 | -13.4770889488 | 3.71 | 4.6054 | 1.96 | 15539 | 3.2795615 | CS |
| 52 | -3.005 | -48.35076428 | 6.215 | 6.7738 | 1.96 | 14244 | 3.41570307 | CS |
| 156 | -3.005 | -48.35076428 | 6.215 | 6.7738 | 1.96 | 14244 | 3.41570307 | CS |
| 260 | -3.005 | -48.35076428 | 6.215 | 6.7738 | 1.96 | 14244 | 3.41570307 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
